NASDAQ NMS - GLOBAL MARKET · RGC
+3.54% · +$0.2100 · Vol 191.8K
Market closed · last close 4:00 PM ET · price as of 19:25:57 ET
Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd

Pharmaceuticals
$6.15
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for RGC until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is RGC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RGC catalysts
About Regencell Bioscience Holdings Ltd
Pharmaceuticals
Listed since
2021
Employees
10
Country
HK

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.93
Day high
$6.20
Day low
$5.63
Previous close
$5.94
52W high
$52.88
-88.37% from high
52W low
$4.78
3% of range
Market cap
$2.9B
P/E
7.69×
EPS
$0.8000
Beta
0.98
Shares out
494.5M
Volume
191.8K
0.40× rel vol
Avg volume
475.9K
VWAP
$6.01
Price history computed in-house
1W
+7.52%
1M
-3.45%
3M
-78.88%
1Y
-52.58%
YTD
-70.71%
SMA 50 $12.70 · below
SMA 200 $21.12 · below
52W position 3%

RGC overview

Loading financial statements
Loading RGC Form 4 filings
Public disclosures

Congress activity in RGC

Federal contracts

RGC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RGC in this window.
Lobbying spend

RGC lobbying filings, year to date.

Registered lobbying filings matched to Regencell Bioscience Holdings Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RGC in this window.
Loading news for RGC
Analyst ratings
Sovereign unlock shows live analyst consensus for RGC.
Options
Sovereign unlock shows live options positioning for RGC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.